Q1 2026 Holdings
Filed 2026-05-15 | 33 holdings | $895.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $62.1M | 104,726 | 6.9% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $51.9M | 465,869 | 5.8% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $51.7M | 695,718 | 5.8% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $45.8M | 786,844 | 5.1% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $45.5M | 468,376 | 5.1% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $43.2M | 513,770 | 4.8% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $40.6M | 248,475 | 4.5% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $37.9M | 370,344 | 4.2% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $37.0M | 400,464 | 4.1% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $36.5M | 947,339 | 4.1% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $33.0M | 1,190,118 | 3.7% |
| Axsome Therapeutics Inc.(AXSM) | COM | 05464T104 | $31.9M | 188,772 | 3.6% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $29.1M | 873,838 | 3.3% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $25.6M | 2,017,284 | 2.9% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $24.5M | 623,839 | 2.7% |
| Celcuity Inc(CELC) | COM | 15102K100 | $24.0M | 210,578 | 2.7% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $21.9M | 446,390 | 2.5% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $21.2M | 254,672 | 2.4% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $18.7M | 283,700 | 2.1% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $18.5M | 220,921 | 2.1% |
| Palvella Therapeutics Inc NE(PVLA) | COM | 697947109 | $18.5M | 148,093 | 2.1% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $17.9M | 558,336 | 2.0% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $17.8M | 911,337 | 2.0% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $17.5M | 76,300 | 1.9% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $17.3M | 2,256,109 | 1.9% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $17.2M | 326,694 | 1.9% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $17.0M | 422,023 | 1.9% |
| Natera Inc(NTRA) | COM | 632307104 | $16.2M | 81,077 | 1.8% |
| Erasca Inc(ERAS) | COM | 29479A108 | $14.0M | 867,639 | 1.6% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $13.7M | 42,441 | 1.5% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $11.5M | 768,662 | 1.3% |
| Uniqure NV(QURE) | SHS | N90064101 | $10.1M | 615,489 | 1.1% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $5.9M | 315,563 | 0.7% |